Gene-Edited stem cells aim to tame HIV
NCT ID NCT02500849
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving HIV patients their own genetically modified stem cells is safe and feasible. The cells are changed to resist HIV, and patients receive a mild chemotherapy drug before infusion. The goal is to see if the modified cells can help control the virus, but this is an early safety trial with only 12 participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Circle CARE Center, LLC
Norwalk, Connecticut, 06850, United States
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
Mills Clinical Research
Los Angeles, California, 90069, United States
-
Quest Clinical Research
San Francisco, California, 94115, United States
-
UCLA CARE Center
Los Angeles, California, 90035, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer support may lift the cloud of loneliness for older gay men with HIV
- Can peer mentors help gay men with HIV stay in care?
- HIV and hidden health risks: a major study probes the link
- Faith-Based therapy aims to heal trauma in young women
- Bringing HIV care to the community: a new test in zambia
- Could intense workouts reverse cognitive decline in older HIV patients?